Back to Search
MACON MORRIS, MD
MD
Emergency Medicine Physician
NPI: 1780171587IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
28953(MS)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Class of 2018
Research & Publications (20)
A novel physiological investigation of the functional residual capacity by the bias flow nitrogen washout technique in infants.
PMID 19499588·Pediatr Pulmonol·2009
8-other
Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer.
PMID 19364960·J Clin Oncol·2009
3-trial
Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer.
PMID 19375217·Eur Urol·2009
3-trial
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumors.
PMID 17473203·Clin Cancer Res·2007
3-trial
Paclitaxel and carboplatin versus mitoxantrone: lessons of an underpowered study.
PMID 17019430·Nat Clin Pract Oncol·2006
8-other
Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail.
PMID 17028241·Eukaryot Cell·2006
7-preclinical
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer.
PMID 15869719·Curr Urol Rep·2005
6-review
Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.
PMID 16243819·Clin Cancer Res·2005
3-trial
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy.
PMID 15867215·Clin Cancer Res·2005
4-observational
Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer.
PMID 15722787·Appl Immunohistochem Mol Morphol·2005
3-trial
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
PMID 15112267·Cancer·2004
4-observational
Targeting osseous metastases: rationale and development of radio-immunotherapy for prostate cancer.
PMID 15066234·Curr Oncol Rep·2004
6-review
Neospora caninum expresses an unusual single-domain Kazal protease inhibitor that is discharged into the parasitophorous vacuole.
PMID 15111091·Int J Parasitol·2004
7-preclinical
Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer Center.
PMID 12850524·Crit Rev Oncol Hematol·2003
6-review
Novel therapies for the treatment of prostate cancer: current clinical trials and development strategies.
PMID 12031864·Surg Oncol·2002
6-review
Novel strategies and therapeutics for the treatment of prostate carcinoma.
PMID 11002230·Cancer·2000
6-review
Does parent report measure performance? A study of the construct validity of the Functional Mobility Scale.
PMID 19549200·Dev Med Child Neurol·2010
8-other
Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo.
PMID 19499569·J Pharm Sci·2010
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4500 13TH ST
GULFPORT, MS 39501 - Phone
- (228) 867-4000
Quick Facts
- NPI
- 1780171587
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile